Arteriocyte Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Arteriocyte

Access the complete profile.

Arteriocyte Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	7100 Euclid Ave. Cleveland, OH 44103

Note: Revenues for privately held companies are statistical evaluations.


Arteriocyte's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Arteriocyte's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Arteriocyte is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Trademark Applications

Trademark applications show the products and services that Arteriocyte is developing and marketing. Arteriocyte doesn't have any recent trademark applications, indicating Arteriocyte is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ARTERIOCYTE Bacteriological consultation, research, and testing; Biological research; Chemical, biochemical, biological and bacteriological research and analysis; Medical research; Pharmaceutical research and development; Product research and development; Research and development of new products; Research and development of vaccines and medicines; Scientific research and development	07/29/2008

See all trademarks and details in the Full Report.

Market Share of Arteriocyte's Largest Competitors

A competitive analysis shows these companies are in the same general field as Arteriocyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Arteriocyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SPR THERAPEUTICS	Cleveland, OH	100
VIEWRAY	Oakwood Village, OH	84
CELLULAR TECHNOLOGY LIMITED	Shaker Heights, OH	55
NDI MEDICAL	Cleveland, OH	36
POWDERMET	Euclid, OH	19
OHIO LUMEX	Solon, OH	15

Future Competition: Arteriocyte's Fastest Growing Competitors

These companies are in the same general field as Arteriocyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)